Loading company…
Shenzhen Shenxin develops mRNA delivery technology, vaccines, and medicines.
Shenzhen Shenxin develops vaccines and drugs using mRNA and lipid nanoparticle delivery technology. Its research pipelines cover infectious disease vaccines, rare diseases, therapeutic oncology vaccines, and oncology immunotherapy boosters. Founded in 2019, the company is based in Shenzhen and has R&D labs there, in Nanjing, and in Hong Kong.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in